Medable Stock
Medable is transforming clinical research and predictive medicine by creating a platform powered by patient generated data.
Sign up today and learn more about Medable Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Medable Stock
Medable provides a global decentralized trial platform that streamlines design, recruitment, retention, and data quality, replacing siloed systems with integrated digital tools, data, and interfaces to accelerate trial execution. The platform connects patients, sites, and clinical trial teams to improve patient access, experience, and outcomes. It is now used by leading biopharma sponsors and clinical research organizations worldwide and has been used for trials in 30+ countries and 26 languages. It was founded in 2015 and is headquartered in Palo Alto, California.
Funding History
| January 2012 | $928K |
|---|---|
| February 2017 | $3.9M |
| April 2020 | $28.6M |
| April 2020 | $17.6M |
| October 2020 | $96.2M |
| April 2021 | $78.9M |
| September 2021 | $305M |
Management
Co-Founder & Chief Architect
James Sas
Co-Founder & CEO
Michelle Longmire
Co-Founder & CTO
Tim Smith
Director of Mobile Development
Fernando Waigandt
Chief Design Officer
Sina Mossayeb
Chief Growth Officer
Sanskriti Thakur
CFO
Jason Sauvie
VP Partner Strategy
Steve Lesser
Senior Vice President, Engineering
Michael Deerkoski
SVP, Strategy and Solutions
Ching Tian
EVP Sales
Eric M. Peper
VP User Experience
Andrew Purcell
General Counsel, Secretary & Chief Compliance Officer
Perry Robinson
VP Customer Success
Jared Klingeisen
VP Product Management
Niraj Patel
Board Observer
Cathy Gao
Chief Product Officer
Parag Vaish
Senior VP of Marketing
David Swanger
VP Legal & SaMD
Andrea Sanchez
Head of Decentralised Clinical Trials
Alison Holland
VP Mobile Development
Hernan Pelassini
Head of Commercial and Strategic Partnerships
Gillian Livock
Board Member
Sunny Kumar
DevOps Tech Lead
Jacobi Petrucciani
VP Life Sciences
Tyler Pugsley
Board Member
David Hartwig
Director of Product Marketing
Douglas Weatherhead
VP of AI/ML
Gabor Melli
Chief Scientific Officer
Pamela Tenaerts
SVP Research & Academics
Ingrid Oakley-Girvan
Press
businesswire - Jan, 8 2024
Medable’s New Intelligent Automation Capabilities Cut Clinical Trial Technology Deployment Timelines By 50%biospace - Jan, 3 2024
Medable to Present at 42nd Annual J.P. Morgan Healthcare Conferencefiercebiotech - Oct, 7 2023
Medable teams up with Pluto Health to simplify, speed trial recruitmentvator - Feb, 3 2023
Medable and Nova Scotia Health partner to increase clinical trial access in Canadavator - Jan, 5 2023
Medable and Every Cure team up to find new uses for existing drugsEquityZen Recognized As:
